BiomX (PHGE) 10% owner’s entity converts preferred and sells 670,000 shares

Rhea-AI Filing Summary

BiomX Inc. director and 10% owner Yeganeh Reuven, through Pyu Pyu Capital LLC, reported a series of conversions and sales of the company’s stock. Pyu Pyu converted Series Y Convertible Preferred Stock into a total of 670,000 shares of Common Stock at $2.00 per share, then sold those 670,000 Common shares in private transactions at $5.00 per share over March 11–13, 2026. The filing notes the securities are directly owned by Pyu Pyu Capital LLC and may be deemed beneficially owned by Reuven as its sole member, with Reuven disclaiming beneficial ownership except to the extent of his pecuniary interest.

Insights

Insider transactions analyst

Entity linked to a 10% owner converted and sold 670,000 BiomX shares.

The filing shows Pyu Pyu Capital LLC, associated with director and 10% owner Yeganeh Reuven, converting Series Y Convertible Preferred Stock into 670,000 BiomX common shares at $2.00 per share. All of these shares were then sold in private transactions at $5.00 per share on March 11–13, 2026.

This pattern is an exercise-and-sell sequence: derivative conversion followed by full share disposal. The reporting person disclaims beneficial ownership beyond pecuniary interest, so the activity is attributed to Pyu Pyu Capital LLC. The transactions result in a net sale of 670,000 common shares, and there is no remaining common stock position reported for this entity after the sales.

The economic signal is a complete exit from the reported common stock holdings by an entity linked to a 10% owner. Actual implications for BiomX depend on factors not detailed here, such as total shares outstanding, broader shareholder base, and any future disclosures in company filings about ownership changes.

Insider Trade Summary

Net Seller: 670,000 shares ($3,350,000)

Net Sell 6 txns

Insider Yeganeh Reuven

Role Director, 10% Owner

Sold 670,000 shs ($3.35M)

Type	Security	Shares	Price	Value
Conversion	Series Y Convertible Preferred Stock	740	$0.00	--
Conversion	Common Stock, $0.0001 par value per share	370,000	$2.00	$740K
Sale	Common Stock, $0.0001 par value per share	370,000	$5.00	$1.85M
Conversion	Series Y Convertible Preferred Stock	600	$0.00	--
Sale	Common Stock, $0.0001 par value per share	300,000	$5.00	$1.50M
Conversion	Common Stock, $0.0001 par value per share	300,000	$2.00	$600K

Holdings After Transaction: Series Y Convertible Preferred Stock — 1,960 shares (Indirect, Pyu Pyu Capital LLC); Common Stock, $0.0001 par value per share — 370,000 shares (Indirect, Pyu Pyu Capital LLC)

Footnotes (1)

1. Represents shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer received upon conversion of the Issuer's Series Y Convertible Preferred Stock, par value $0.0001 per share, held by the Reporting Person at a conversion price equal to $2.00 per share. The reported securities are directly owned by Pyu Pyu Capital, LLC ("Pyu Pyu") and may be deemed to be beneficially owned by the Reporting Person as sole member of Pyu Pyu. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The shares of Common Stock were sold in private transactions at a price of $5.00 per share.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yeganeh Reuven

(Last) (First) (Middle)

C/O BIOMX INC.

22 EINSTEIN ST., FLOOR 4

(Street)

NESS ZIONA IL 414003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BiomX Inc. [ PHGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value per share	03/11/2026		C(1)		300,000	A	$2(1)	30,000	I	Pyu Pyu Capital LLC(2)
Common Stock, $0.0001 par value per share	03/12/2026		S(3)		300,000	D	$5(3)	0	I	Pyu Pyu Capital LLC(2)
Common Stock, $0.0001 par value per share	03/13/2026		C(1)		370,000	A	$2(1)	370,000	I	Pyu Pyu Capital LLC(2)
Common Stock, $0.0001 par value per share	03/13/2026		S(3)		370,000	D	$5(3)	0	I	Pyu Pyu Capital LLC(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series Y Convertible Preferred Stock	$2(1)	03/12/2026		C(1)			600	01/13/2026	01/13/2027	Common Stock	300,000	$0(1)	2,700	I	Pyu Pyu Capital LLC(2)
Series Y Convertible Preferred Stock	$2(1)	03/13/2026		C(1)			740	01/13/2026	01/13/2027	Common Stock	370,000	$0(1)	1,960	I	Pyu Pyu Capital LLC(2)

Explanation of Responses:

1. Represents shares of common stock, par value $0.0001 per share ("Common Stock"), of the Issuer received upon conversion of the Issuer's Series Y Convertible Preferred Stock, par value $0.0001 per share, held by the Reporting Person at a conversion price equal to $2.00 per share.

2. The reported securities are directly owned by Pyu Pyu Capital, LLC ("Pyu Pyu") and may be deemed to be beneficially owned by the Reporting Person as sole member of Pyu Pyu. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

3. The shares of Common Stock were sold in private transactions at a price of $5.00 per share.

	/s/ Reuven Yeganeh	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did BiomX (PHGE) report for Yeganeh Reuven and Pyu Pyu Capital LLC?

Pyu Pyu Capital LLC, linked to director and 10% owner Yeganeh Reuven, converted Series Y preferred stock into 670,000 BiomX common shares at $2.00 per share, then sold all 670,000 shares in private transactions at $5.00 per share during March 11–13, 2026.

How many BiomX (PHGE) shares were sold in the latest Form 4?

The Form 4 reports that 670,000 shares of BiomX common stock were sold. These sales were executed by Pyu Pyu Capital LLC in private transactions at a price of $5.00 per share, following conversions of Series Y Convertible Preferred Stock into common stock.

At what prices did the insider-related entity trade BiomX (PHGE) shares?

Pyu Pyu Capital LLC converted preferred shares into BiomX common stock at a $2.00 per share conversion price. It then sold the resulting 670,000 common shares in private transactions at a sale price of $5.00 per share, as disclosed in the Form 4 footnotes.

Who actually owns the BiomX (PHGE) shares reported in Reuven’s Form 4?

The securities are directly owned by Pyu Pyu Capital LLC. The filing states they may be deemed beneficially owned by Yeganeh Reuven as Pyu Pyu’s sole member, while he disclaims beneficial ownership except to the extent of his pecuniary interest in the securities.

Were the BiomX (PHGE) insider sales open-market or private transactions?

The Form 4 footnotes state that the BiomX common shares were sold in private transactions at a price of $5.00 per share. This means the trades did not occur on a public exchange but were privately negotiated between buyer and seller.

What type of securities did Pyu Pyu Capital LLC convert into BiomX (PHGE) common stock?

Pyu Pyu Capital LLC converted Series Y Convertible Preferred Stock of BiomX into common stock. The conversion occurred at a price equal to $2.00 per share, generating 670,000 shares of common stock that were subsequently sold in private transactions.